← FDA DRUG APPROVALS

FDA ANDA · ANDA040486

METAXALONE

Sponsor: MOUNTAIN

APPLICATION
ANDA040486
TYPE
ANDA
ORIGINAL APPROVAL
2015-02-27
LATEST ACTION
2025-05-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

METAXALONEPrescription
METAXALONE 400MG · TABLET · ORAL

Approval history

2025-05-23Labeling · Supplement 15 · standardAP
2019-10-07Labeling · Supplement 7 · standardAP
2015-02-27OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →